Pharmafile Logo
Pharmafocus logo
Advanced Search
800px-social_distancing_queueing_for_the_supermarket_j

Nearly 100,000 people catching coronavirus every day in England, new study suggests

October 29, 2020
Research and Development

Nearly 100,000 people are being infected with COVID-19 each day according to a new study from Imperial College London.  Named …

News
bugbuster

FDA approves Sanofi’s ivermectin head lice treatment for over-the-counter use

October 29, 2020
Sales and Marketing

The FDA has approved Sanofi’s Sklice (ivermectin) for over-the-counter use.  Sklice is a single-use lotion that includes ivermectin 0.5% as …

News
takeda_usa_pharmaceuticals_u

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …

News
robertson_1

Redx Pharma appoints Dr Jane Robertson as Chief Medical Officer

October 29, 2020
Research and Development

Redx Pharma has announced the appointment of Dr Jane Robertson as its new Chief Medical Officer at the company. Robertson …

Appointment
vaccination-1215279_960_720

GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative

October 28, 2020
Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi

Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …

News

Novartis collaborates with Molecular Partners to develop therapies to use against COVID-19

October 28, 2020
Research and Development

Novartis and Molecular Partners AG have announced that they will develop, commercialise and manufacture Molecular’s anti-COVID-19 DARPin programme, which consists …

News
lilly_building_with_american_flag_web

US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal

October 28, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma

The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …

News

80% of COVID-19 patients in study were vitamin D-deficient

October 28, 2020
Research and Development

New research has found that over 80% of COVID-19 patients in a recent study had a vitamin D deficiency.  The …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

October 28, 2020
Research and Development

The coronavirus news this week focuses on clinical trials testing potential vaccines, with the University of Oxford and AstraZeneca stating …

News
pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

October 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir

The latest monthly edition of Pharmafocus is available to read for free online now!

News
sanofi_hq__boetie_hall_web

Sanofi’s Dupixent shows strength at Phase 3 in eosinophilic esophagitis

October 27, 2020
Manufacturing and Production Dupixent, Sanofi, pharma

Sanofi has lifted the curtain on new Phase 3 data for Dupixent (dupilumab), showing that the drug met all of …

News
800px-eli_lilly_corporate_center_indianapolis_indiana_usa_2

Eli Lilly antibody treatment fails COVID-19 study

October 27, 2020
Manufacturing and Production

The US Government is putting an early end to clinical trials testing Eli Lilly’s antibody drug in COVID-19 patients.  The …

News
brain_mri_131749_t1

New trial to test if cancer drug can effectively treat hallucinations in Parkinson’s patients

October 27, 2020
Manufacturing and Production Parkinson's, Parkinson's UK

A new study is set to go ahead that will test if ondansetron is safe and effective in treating Parkinson’s …

News
800px-white_house_dc_2

US could have avoided over 130,000 COVID-19 deaths, according to a new study

October 27, 2020
Manufacturing and Production COVID, COVID-19, Trump, coronavirus

New studies suggest that the US could have avoided over 130,000 deaths if it responded earlier and in a coordinated …

News

Bayer buys out US-based Asklepios BioPharmaceutical in potential $4bn deal

October 26, 2020
Sales and Marketing Asklepios, Bayer, acquisition, pharma

Bayer has moved to bolster its cell and gene therapy (CGT) business through the acquisition of US biotech Asklepios BioPharmaceutical …

News
astrazeneca-sign

AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants

October 26, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine

AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of Oxford, has shown promising immune …

News
800px-industria_novartis_1

Novartis announces positive Phase 2 data of rare renal disease therapy iptacopan

October 26, 2020
Sales and Marketing

Novartis has announced positive Phase 2 interim analysis results for iptacopan, which is an investigational oral treatment for rare renal …

News
706px-fentanyl_lollipops_actiq_400_mcg

UK Government outlines steps to tackle growing misuse of fentanyl

October 26, 2020
Sales and Marketing

The British Government has responded to a report investigating the misuse of fentanyl and painkillers in the UK. In January …

News
800px-who_flag_2

WHO warns regulators to consider all available evidence before approving remdesivir for COVID-19

October 26, 2020
Sales and Marketing COVID, COVID-19, Gilead, coronavirus

The World Health Organization’s Chief Scientist Soumya Swaminathan has warned that experts and regulators assessing the use of Gilead’s remdesivir …

News
me_and_calcin_at_aquarium_usa

Patient Experience: Living with Timothy syndrome

October 26, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Timoty syndrome, feature, patient experience, rare disease

Thirteen-year-old Calvin Muir lives with the ultra-rare genetic condition Timothy syndrome. Like many parents of rare disease patients, his mother …

Feature
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026